TY - JOUR
T1 - Reading Ability as an Estimator of Premorbid Intelligence
T2 - Does It Remain Stable among Ethnically Diverse HIV+ Adults?
AU - Olsen, James P.
AU - Fellows, Robert P.
AU - Rivera-Mindt, Monica
AU - Morgello, Susan
AU - Byrd, Desiree A.
N1 - Publisher Copyright:
© 2015 Taylor & Francis.
PY - 2015/10/3
Y1 - 2015/10/3
N2 - The Wide Range Achievement Test, 3rd edition, Reading Recognition subtest (WRAT-3 RR) is an established measure of premorbid ability. Furthermore, its long-term reliability is not well documented, particularly in diverse populations with CNS-relevant disease. Objective: We examined test-retest reliability of the WRAT-3 RR over time in an HIV+ sample of predominantly racial/ethnic minority adults. Method: Participants (N = 88) completed a comprehensive neuropsychological battery, including the WRAT-3 RR, on at least two separate study visits. Intraclass correlation coefficients (ICCs) were computed using scores from baseline and follow-up assessments to determine the test-retest reliability of the WRAT-3 RR across racial/ethnic groups and changes in medical (immunological) and clinical (neurocognitive) factors. Additionally, Fishers Z tests were used to determine the significance of the differences between ICCs. Results: The average test-retest interval was 58.7 months (SD = 36.4). The overall WRAT-3 RR test-retest reliability was high (r =.97, p <.001) and remained robust across all demographic, medical, and clinical variables (all rs >.92). ICCs did not differ significantly between the subgroups tested (all Fishers Z ps >.05). Conclusions: Overall, this study supports the appropriateness of word-reading tests, such as the WRAT-3 RR, for use as stable premorbid IQ estimates among ethnically diverse groups. Moreover, this study supports the reliability of this measure in the context of change in health and neurocognitive status and in lengthy inter-test intervals. These findings offer strong rationale for reading as a "hold" test, even in the presence of a chronic, variable disease such as HIV.
AB - The Wide Range Achievement Test, 3rd edition, Reading Recognition subtest (WRAT-3 RR) is an established measure of premorbid ability. Furthermore, its long-term reliability is not well documented, particularly in diverse populations with CNS-relevant disease. Objective: We examined test-retest reliability of the WRAT-3 RR over time in an HIV+ sample of predominantly racial/ethnic minority adults. Method: Participants (N = 88) completed a comprehensive neuropsychological battery, including the WRAT-3 RR, on at least two separate study visits. Intraclass correlation coefficients (ICCs) were computed using scores from baseline and follow-up assessments to determine the test-retest reliability of the WRAT-3 RR across racial/ethnic groups and changes in medical (immunological) and clinical (neurocognitive) factors. Additionally, Fishers Z tests were used to determine the significance of the differences between ICCs. Results: The average test-retest interval was 58.7 months (SD = 36.4). The overall WRAT-3 RR test-retest reliability was high (r =.97, p <.001) and remained robust across all demographic, medical, and clinical variables (all rs >.92). ICCs did not differ significantly between the subgroups tested (all Fishers Z ps >.05). Conclusions: Overall, this study supports the appropriateness of word-reading tests, such as the WRAT-3 RR, for use as stable premorbid IQ estimates among ethnically diverse groups. Moreover, this study supports the reliability of this measure in the context of change in health and neurocognitive status and in lengthy inter-test intervals. These findings offer strong rationale for reading as a "hold" test, even in the presence of a chronic, variable disease such as HIV.
KW - HIV/AIDS
KW - Low literacy
KW - Premorbid IQ
KW - Reading tests
KW - Reliability
UR - https://www.scopus.com/pages/publications/84957442258
U2 - 10.1080/13854046.2015.1122085
DO - 10.1080/13854046.2015.1122085
M3 - Article
C2 - 26689235
AN - SCOPUS:84957442258
SN - 1385-4046
VL - 29
SP - 1034
EP - 1052
JO - Clinical Neuropsychologist
JF - Clinical Neuropsychologist
IS - 7
ER -